Dityrosine administration induces dysfunction of insulin secretion accompanied by diminished thyroid hormones T3

Yin-Yi Ding1, Zhu-Qing Li1, Xiang-Rong Cheng1

  • 1Food Nutrition and Functional Factors Research Center, School of Food Science and Technology, Jiangnan University, Wuxi, 214122, China.

Amino Acids
|June 19, 2017
PubMed

Insights

Dityrosine (Dityr), an oxidized tyrosine product, disrupts thyroid hormone (T3) function in the pancreas, leading to impaired glucose metabolism and insulin synthesis disruption in mice.

Area of Science:

  • Endocrinology
  • Metabolism
  • Toxicology

Background:

  • Oxidized tyrosine products, like dityrosine (Dityr), are found in high-protein foods and can damage organs.
  • Dityrosine's structural similarity to thyroid hormone T3 suggests potential endocrine disruption.
  • Thyroid hormone resistance (RTH) is linked to impaired glucose metabolism, highlighting a potential connection.

Purpose of the Study:

  • To investigate if Dityr exposure impairs T3 function in the pancreas.
  • To determine if Dityr disrupts glucose metabolism through pancreatic T3 signaling.

Main Methods:

  • Mice were gavaged with Dityr for 10 weeks.
  • Assessed glucose tolerance, energy metabolism, thyroid hormone levels, and gene/protein expression in thyroid and pancreas.
  • Utilized MIN-6 cell experiments to confirm T3's role in insulin secretion.

Main Results:

  • Dityr exposure impaired glucose tolerance and energy metabolism in mice.
  • Dityr enhanced thyroid hormone synthesis and induced RTH.
  • Pancreatic T3 signaling was suppressed by Dityr, evidenced by downregulated transporter/receptor gene and protein levels, impairing insulin synthesis.

Conclusions:

  • Dityrosine disrupts thyroid hormone function in the pancreas.
  • This disruption leads to impaired glucose metabolism and disordered insulin synthesis.
  • Dityr interferes with T3-regulated insulin synthesis indirectly by reducing pancreatic sensitivity to T3.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.8K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
952
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
7.2K